Quarterly report [Sections 13 or 15(d)]

Selected Financial Statement - Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details)

v3.26.1
Selected Financial Statement - Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Accounts payable:    
Clinical and regulatory expenses $ 441 $ 565
Professional fees 844 927
Selling expenses 1,580 1,721
Manufacturing costs 1,724 1,466
Non-employee director compensation 1,006 1,018
Other vendors 215 282
Total accounts payable 5,810 5,979
Accrued interest payable, related parties 1,534 1,474
Accrued interest payable 6,905 5,841
Accrued expenses:    
Payroll expenses 382 452
Government rebates and other rebates 9,294 8,538
Other accrued expenses 562 331
Total accrued expenses 10,238 9,321
Total accounts payable and accrued expenses $ 24,487 $ 22,615